BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Unixell Biotech Secures US FDA IND Clearance For iPSC Derived Epilepsy Cell Therapy

Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational N...

March 16, 2026 | News

Locus Cell And Charles River Sign Strategic MoU To Advance Cell And Gene Therapy Manufacturing In APAC

Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles Riv...

March 13, 2026 | News

Merck And Cyto Facto Partner To Advance Lentiviral Manufacturing For Cell And Gene Therapies In APAC

Collaboration aims to support development of a robust lentiviral production platform for gene therapy applications Merck’s VirusExpress™293T...

March 12, 2026 | News

Tsingke Biotech And iGeneTech Form Strategic Alliance To Accelerate Synthetic Biology Innovation

Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at adva...

March 11, 2026 | News

BrainXell Launches Human iPSC Derived Sensory Neurons Platform To Advance Pain And Ion Channel Research

BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineer...

March 06, 2026 | News

Terumo BCT Launches C&GT Ecosystem Blueprint To Enable Scalable Cell And Gene Therapy Development In APAC

A collaborative integration model to enable practical, scalable cell and gene therapy delivery. Terumo Blood and Cell Technologies (Terumo BCT) annou...

March 06, 2026 | News

Antengene Grants UCB Global Rights To Develop And Commercialise ATG 201 Bispecific T Cell Engager

Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, t...

March 05, 2026 | News

ISCT And JSRM Form Five Year Global Partnership To Accelerate Clinical iPSC Therapies

The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese So...

March 05, 2026 | News

XellSmart Secures Fourth Dual US And China Regulatory Clearance For iPSC Derived Cell Therapy In Multiple System Atrophy

XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for P...

March 04, 2026 | News

PHCbi Launches LiCellGrow Cell Expansion System To Advance CGT Manufacturing Efficiency

PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provid...

March 03, 2026 | News

Takeda And Protagonist Secure FDA Priority Review For Rusfertide In Polycythemia Vera

Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythem...

March 03, 2026 | News

Japan Launches Elevidys Gene Therapy For Young Children With Duchenne Muscular Dystrophy

- Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years - Company is eligible ...

February 27, 2026 | News

Astellas And Vir Biotechnology Forge Global Partnership To Advance VIR 5500 In Prostate Cancer

- Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues - - Astellas to lead commerci...

February 25, 2026 | News

iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones

The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...

February 25, 2026 | News

Stay Connected